Literature DB >> 8030756

A novel approach to the characterization of whole prostate pathology in glycol methacrylate.

L E Monger1, M Nagabhushan, T G Pretlow, T P Pretlow.   

Abstract

The controversial and subjective nature of the classification of many prostatic lesions and the increasing recognition that lesions that occur in different topographical regions or zones of the prostate may differ in their biological behavior suggest that new approaches are needed to increase our understanding of the biology of prostatic diseases. The precise recognition and identification of prostatic lesions are prerequisites for studies of their biological behavior. We have developed a novel method for the embedding of whole prostates in glycol methacrylate at low temperatures. Enzyme histochemical procedures that can be conducted with this approach have revealed previously unrecognized features of prostatic intraepithelial neoplasia and have demonstrated the presence of prostatic lesions that resemble enzyme-altered foci that have been reported and characterized extensively in other organ systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030756      PMCID: PMC1887311     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  National Cancer Institute roundtable on prostate cancer: future research directions.

Authors:  A Chiarodo
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

2.  Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity.

Authors:  T P Pretlow; M A O'Riordan; M F Kolman; J A Jurcisek
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

3.  Transplantation of human prostatic carcinoma into nude mice in Matrigel.

Authors:  T G Pretlow; C M Delmoro; G G Dilley; C G Spadafora; T P Pretlow
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

4.  Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.

Authors:  R R Rackley; B Yang; T G Pretlow; F W Abdul-Karim; T J Lewis; N McNamara; C M Delmoro; E L Bradley; E Kursh; M I Resnick
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

5.  Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia.

Authors:  T G Pretlow; T P Pretlow; B Yang; C S Kaetzel; C M Delmoro; S M Kamis; D R Bodner; E Kursh; M I Resnick; E L Bradley
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

Review 6.  The association of benign prostatic hyperplasia and cancer of the prostate.

Authors:  D G Bostwick; W H Cooner; L Denis; G W Jones; P T Scardino; G P Murphy
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

7.  Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.

Authors:  R B Nagle; M K Brawer; J Kittelson; V Clark
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections.

Authors:  T T Casey; S J Olson; J B Cousar; R D Collins
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

9.  K-ras mutations in putative preneoplastic lesions in human colon.

Authors:  T P Pretlow; T A Brasitus; N C Fulton; C Cheyer; E L Kaplan
Journal:  J Natl Cancer Inst       Date:  1993-12-15       Impact factor: 13.506

10.  Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.

Authors:  D R Greene; T M Wheeler; S Egawa; R P Weaver; P T Scardino
Journal:  Br J Urol       Date:  1991-11
View more
  2 in total

1.  Evaluation of non-formalin tissue fixation for molecular profiling studies.

Authors:  John W Gillespie; Carolyn J M Best; Verena E Bichsel; Kristina A Cole; Susan F Greenhut; Stephen M Hewitt; Mamoun Ahram; Yvonne B Gathright; Maria J Merino; Robert L Strausberg; Jonathan I Epstein; Stanley R Hamilton; Gallya Gannot; Galina V Baibakova; Valerie S Calvert; Michael J Flaig; Rodrigo F Chuaqui; Judi C Herring; John Pfeifer; Emmanuel F Petricoin; W Marston Linehan; Paul H Duray; G Steven Bova; Michael R Emmert-Buck
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Expression of E-cadherin in primary and metastatic prostate cancer.

Authors:  L Cheng; M Nagabhushan; T P Pretlow; S B Amini; T G Pretlow
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.